IGF2BP2 and hepatocellular carcinoma: For the RT-qPCR results, the expression of IDH2 was notably reduced, and MRPS23, MPV17, CDK5, MAPK3, and IGF2BP2 were markedly overexpressed in clinical HCC samples versus control samples, which were in accordance with the results in online datasets above (Fig. 8C).